How global biomed leader Xeltis used Indeemo to bridge the gap between patient homes and clinical sites, ensuring Nobel Prize-winning technology delivers life-saving results.
With breakthrough trials underway in the US, Xeltis faced a clinical blind spot. Traditional appointments left surgeons unable to monitor healing in real-time.
Without Indeemo, we would be far behind. Problems often become critical before researchers have any idea of what is happening.
Senior US Clinical Care Specialist, Xeltis
Indeemo redefined the standard of care for Xeltis patients by providing a continuous visual audit trail.
20
US trial sites
Consistent visibility across all primary US clinical locations.
Weekly
Safety checks
52 points of visibility per year, replacing sporadic clinic visits.
100%
Patient ownership
Empowering patients to monitor their own canulation rotation.
Zero
Missed criticals
Identifying issues early before they escalate to septic events.
Hear Xeltis Senior US Clinical Care Specialist Nancy Foss | RN, CNN discuss the transformative potential of real-life evidence in healthcare.
"The core value is really enhancing the quality of patient care. It gives us eyes on access weekly."
"Facilitates care by enabling the patient to take ownership and monitor rotation of sites."
The platform capabilities that allowed Xeltis to scale oversight efficiently across multiple clinical sites.
Deploy trials across borders with ease. Support for 34 languages ensures the platform is ready to scale from US trials to international markets seamlessly.
Build a multi-year audit trail of real-world evidence. Track healing and device efficacy from initial implant through to full resorption over long-term study periods.
Protect sensitive PHI with enterprise-grade HIPAA compliance, facial blurring, and secure, encrypted data handling built for clinical research standards.
Learn how real-life evidence can transform your trial oversight. Complete the form below to book a demo with our team.